Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Infante

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Neurogenetics|March 25, 2009
Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern SpainIgnacio F Mata, Carolyn M Hutter, María C González-Fernández, et al.
Brain Communications|February 20, 2025
<i>HTT, ATXN1</i> and <i>ATXN2</i> CAG triplet repeat sizes: exploring their role in the disease risk and cancer comorbidity in Parkinson's diseaseSergio Pérez-Oliveira, Ignacio Álvarez, Manuel Menéndez-González, et al.
Brain : a Journal of Neurology|April 18, 2023
Blood transcriptome sequencing identifies biomarkers able to track disease stages in spinocerebellar ataxia type 3Mafalda Raposo, Jeannette Hübener-Schmid, Ana F Ferreira, et al.
Neurobiology of Disease|February 7, 2026
Cognitive impairment in SCA3: A multi-center cohort study with demographic, imaging, and biomarker correlatesRoderick P P W M Maas, Hector Garcia-Moreno, Jennifer Faber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2014
The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study)Claustre Pont-Sunyer, Anna Hotter, Carles Gaig, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 16, 2021
Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJeannette Hübener-Schmid, Kirsten Kuhlbrodt, Julien Peladan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 29, 2021
Characterization of Lifestyle in Spinocerebellar Ataxia Type 3 and Association with Disease SeverityHolger Hengel, Peter Martus, Jennifer Faber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 9, 2022
Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3Roderick P P W M Maas, Steven Teerenstra, Manuela Lima, et al.
CNS Drugs|October 17, 2025
The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI CohortPatrick Silva, Marina A Costa, Laetitia Gaspar, et al.
Neurobiology of Disease|February 29, 2024
Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph diseaseMafalda Raposo, Jeannette Hübener-Schmid, Rebecca Tagett, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Neurogenetics|March 25, 2009
Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern SpainIgnacio F Mata, Carolyn M Hutter, María C González-Fernández, et al.
Brain Communications|February 20, 2025
<i>HTT, ATXN1</i> and <i>ATXN2</i> CAG triplet repeat sizes: exploring their role in the disease risk and cancer comorbidity in Parkinson's diseaseSergio Pérez-Oliveira, Ignacio Álvarez, Manuel Menéndez-González, et al.
Brain : a Journal of Neurology|April 18, 2023
Blood transcriptome sequencing identifies biomarkers able to track disease stages in spinocerebellar ataxia type 3Mafalda Raposo, Jeannette Hübener-Schmid, Ana F Ferreira, et al.
Neurobiology of Disease|February 7, 2026
Cognitive impairment in SCA3: A multi-center cohort study with demographic, imaging, and biomarker correlatesRoderick P P W M Maas, Hector Garcia-Moreno, Jennifer Faber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2014
The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study)Claustre Pont-Sunyer, Anna Hotter, Carles Gaig, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 16, 2021
Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJeannette Hübener-Schmid, Kirsten Kuhlbrodt, Julien Peladan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 29, 2021
Characterization of Lifestyle in Spinocerebellar Ataxia Type 3 and Association with Disease SeverityHolger Hengel, Peter Martus, Jennifer Faber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 9, 2022
Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3Roderick P P W M Maas, Steven Teerenstra, Manuela Lima, et al.
CNS Drugs|October 17, 2025
The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI CohortPatrick Silva, Marina A Costa, Laetitia Gaspar, et al.
Neurobiology of Disease|February 29, 2024
Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph diseaseMafalda Raposo, Jeannette Hübener-Schmid, Rebecca Tagett, et al.
Pageof 15